MAP2K7 and colorectal cancer: We next used HCT116 and SW480 colorectal cancer cell lines, initially with the cobimetinib (MEK inhibitor; Supplementary Table 3) and pictilisib (class I PI3K inhibitor) to establish the combination methodology.